Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 31, 2026, titled "Lannett Company LLC, a wholly owned step down subsidiary of the Company announces launch of generic version of Advair Diskus® in the US".
Aurobindo Pharma Ltd Press Release Aug 31 2026
Filed with NSE · · 3 pages · English
Release
Earlier from Aurobindo Pharma
- Aurobindo Pharma Ltd Press Release Aug 05 2026
- Aurobindo Pharma Ltd Press Release Jul 24 2026
- Aurobindo Pharma Ltd Press Release Jun 22 2026
- Press Release Jun 04 2026
- Press Release Jun 03 2026
Later from Aurobindo Pharma
- Aurobindo Pharma Ltd Press Release Sep 15 2026
- Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 30, 2026, titled "Acrotech Biopharma Launches ADQUEY in the U.S. and Establishes Dedicated Dermatology Business".
- Aurobindo Pharma Ltd Press Release Sep 30 2026
- Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 03, 2026, titled "Aurobindo Pharma receives USFDA Final Approval for Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg".
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma